Cannabis Use Disorder Is the Leading Cause of Drug Use Disorder Prevalence Worldwide

Global burden of disease data from 1990-2021 shows cannabis use disorder has the highest prevalence among all drug use disorders, while opioid use disorder causes the most disability and death.

Jin, Ruiying et al.·Frontiers in public health·2025·Moderate Evidenceecological study
RTHC-06759Ecological studyModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
ecological study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Cannabis use disorder leads all five drug use disorder categories in age-standardized prevalence rates globally. Opioid use disorder has the highest disability and mortality rates. The burden of drug use disorders is significantly greater in high-SDI (high-income) areas, with income inequality exacerbating uneven distribution of disability-adjusted life years.

Key Numbers

Cannabis use disorder has the highest ASPR among 5 drug use disorder categories. Opioid use disorder has the highest ASDR and ASMR. High-SDI areas bear significantly greater burden. Opioid use disorder ASIR declining least among 5 categories.

How They Did This

Analysis of Global Burden of Disease (GBD) 2021 data examining incidence, prevalence, mortality, and DALYs for drug use disorders. Decomposition analysis for age, gender, and SDI effects. Health inequality analysis using slope index and concentration index.

Why This Research Matters

Establishing that cannabis use disorder is the most prevalent drug use disorder globally provides important context for legalization debates and healthcare resource allocation.

The Bigger Picture

The concentration of drug use disorder burden in high-income regions challenges the perception that substance use disorders are primarily a developing-world problem. The finding that income inequality worsens the distribution highlights structural determinants of addiction.

What This Study Doesn't Tell Us

GBD estimates rely on available data that varies greatly by country and region. Cannabis use disorder diagnostic criteria have changed over time. Some countries have minimal surveillance data. Cannot distinguish between cannabis use and cannabis use disorder in many settings.

Questions This Raises

  • ?How will cannabis legalization trends affect global CUD prevalence in coming decades?
  • ?Why is opioid use disorder ASIR declining less than other drug categories?

Trust & Context

Key Stat:
Cannabis use disorder has the highest prevalence rate of any drug use disorder globally
Evidence Grade:
GBD data provides the most comprehensive global estimates available, though data quality varies significantly by country and diagnostic standards have evolved.
Study Age:
2025 publication with 1990-2021 GBD data.
Original Title:
Global, regional and national burden of drug use disorders, 1990-2021: decomposition analysis, health inequality analysis and predictions to 2035.
Published In:
Frontiers in public health, 13, 1588607 (2025)
Database ID:
RTHC-06759

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-06759·https://rethinkthc.com/research/RTHC-06759

APA

Jin, Ruiying; Zhang, Shenyu; Xiong, Jun; Liu, Baixi. (2025). Global, regional and national burden of drug use disorders, 1990-2021: decomposition analysis, health inequality analysis and predictions to 2035.. Frontiers in public health, 13, 1588607. https://doi.org/10.3389/fpubh.2025.1588607

MLA

Jin, Ruiying, et al. "Global, regional and national burden of drug use disorders, 1990-2021: decomposition analysis, health inequality analysis and predictions to 2035.." Frontiers in public health, 2025. https://doi.org/10.3389/fpubh.2025.1588607

RethinkTHC

RethinkTHC Research Database. "Global, regional and national burden of drug use disorders, ..." RTHC-06759. Retrieved from https://rethinkthc.com/research/jin-2025-global-regional-and-national

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.